Completed

Minayo Iron-rich Gummies for Female Anemia and Skin Health

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Minayo Iron-rich Nutritional Gummies

+ Common Gummies

Dietary Supplement
Who is being recruted

Anemia+2

+ Hematologic Diseases

+ Hemic and Lymphatic Diseases

From 18 to 45 Years
+21 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Placebo-Controlled
Interventional
Study Start: March 2025
See protocol details

Summary

Principal SponsorHangzhou Agile Groups Network Technology Co., Ltd.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 17, 2025

Actual date on which the first participant was enrolled.

This study is exploring the effects of Minayo Iron-rich Nutritional Gummies on women aged 18 to 45 who experience nutritional anemia, skin issues, and a condition known as Qi-blood deficiency syndrome. The research aims to determine if these gummies can improve anemia, which is checked by looking at specific blood levels like serum ferritin and hemoglobin. By focusing on this group, the study hopes to find better ways to manage these health challenges, potentially offering a simple nutritional solution to improve overall well-being and address specific symptoms associated with these conditions. Participants in this study are divided into two groups. One group receives the Minayo Iron-rich Nutritional Gummies, while the other receives regular gummies that have no active ingredients, known as a placebo. The study lasts for four weeks, during which participants visit the study center in Shanghai three times for evaluations. Researchers collect clinical data during these visits to analyze and compare the outcomes between the two groups. The main focus is to see if there is a noticeable improvement in anemia, skin conditions, and Qi-blood deficiency symptoms for those taking the Minayo gummies compared to the placebo group.

Official TitleA Randomized, Double-blind, Placebo-controlled Trial of the Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome
NCT06869824
Principal SponsorHangzhou Agile Groups Network Technology Co., Ltd.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

36 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AnemiaHematologic DiseasesHemic and Lymphatic DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Criteria

9 inclusion criteria required to participate
Female subjects, aged 18 to 45;
36 young women with mild anemia (hemoglobin value between 90-110 g/l) were recruited based on WHO diagnostic criteria for anemia. 10 of the subjects always have coffee and milk tea more than once per day;
Participants agree not to take any drugs, supplements, or other dairy products during the trial;
Participants agree not to take any other medications or supplements containing iron during the trial;
Show More Criteria
12 exclusion criteria prevent from participating
Anemia due to organic conditions;
Subject who is in the treatment of gastrointestinal symptoms;
Lactose intolerance;
Subject who is currently presence of other organic diseases affecting intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Active Comparator
Minayo Iron-rich Nutritional Gummies, 3g/piece, each piece contains 7mg of iron. Main ingredients: Maltitol liquid, isomaltitol, erythritol, gelatin, ferrous gluconate, ferrous fumarate, ferric ammonium citrate, acerola cherry powder, cranberry powder, red beetroot powder, raspberry powder, acai powder, salmon hydrolyzed protein peptides, blood protein polypeptides, albumin peptides, Vitamin B1, Vitamin B2, Vitamin B6, Vitamin C, α-cyclodextrin, purple carrot concentrated juice, grape skin extract, agar, citric acid, DL-malic acid, natural food flavoring, octane, glyceryl caprate, and carnauba wax ..

Group II

Placebo
common gummies with main ingredient - Maltodextrin, 3g/piece

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Shanghai Raison CMA Lab

Shanghai, ChinaOpen Shanghai Raison CMA Lab in Google Maps
CompletedOne Study Center